FY2025 · ended Dec 31, 2025 · Revenue $11.54M, +39.5% YoY · Filed Mar 10, 2026
Cardiff Lexington Corporation (CDIX) files with the SEC under industry code 8011, Services-Offices & Clinics of Doctors of Medicine. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $11.5 million and a net loss of $5.5 million. As of Jun 30, 2026 it held $217,654 in cash and investments and $22.8 million in total debt.
Revenue (TTM)
$10.21M
+0.3% vs year-ago TTM
Net income (TTM)
$-9.40M
-105.9% vs year-ago TTM
Operating cash flow
$-2.85M
-3.2% vs prior year
Free cash flow
$-1.10M
-28.8% vs prior year
EPS (TTM)
$-0.80
+63.9% vs year-ago TTM
Dividend per share
None
Shares outstanding
15.16M
-23.0% vs prior year
Net cash
$-22.62M
as of Jun 30, 2026
Operating margin
-10.9%
FY 2026
Company profile
- Industry
- Services-Offices & Clinics of Doctors of Medicine (SIC 8011)
- Listed as
- CDIX (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- FL
- Headquarters
- Lexington, KY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 811222
- Former names
- CARDIFF INTERNATIONAL INC (until Jan 26, 2018)
Other Services-Offices & Clinics of Doctors of Medicine companies
- Hims & Hers Health, Inc. HIMS
- Teladoc Health, Inc. TDOC
- Starling Oncology, Inc. STLN
- SBC Medical Group Holdings Inc SBC
- Auna S.A. AUNA
- Airsculpt Technologies, Inc. AIRS
- LifeMD, Inc. LFMD
- Westin Acquisition Corp WSTN
All 12 Services-Offices & Clinics of Doctors of Medicine companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $11.5M | $8.3M | $11.9M | $10.7M | $9.9M |
| Operating income | $1.1M | -$193,504 | $5.2M | $3.9M | $1.7M |
| Net income | -$5.5M | -$3.3M | $3.0M | -$5.4M | $666,293 |
| Diluted EPS | — | — | — | — | -$0.01 |
| Operating cash flow | -$2.9M | -$2.8M | -$1.8M | -$1.1M | -$850,141 |
| Free cash flow | — | — | — | -$1.1M | -$853,548 |
| Total assets | $29.1M | $23.9M | $20.7M | $13.3M | $15.3M |
| Total liabilities | $26.0M | $16.3M | $14.1M | $10.2M | $11.4M |
| Stockholders' equity | -$2.5M | $2.7M | $731,418 | -$1.7M | $486,840 |
| Cash and investments | $318,535 | $1.2M | $866,943 | $219,085 | $580,968 |
| Total debt | $18.8M | $9.6M | $2.6M | $382,776 | $899,481 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Sep 24, 2026 | Sep 24, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Sep 4, 2026 | Aug 31, 2026 |
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement
|
Jun 11, 2026 | Jun 5, 2026 |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| 10-K | Annual report | Mar 10, 2026 | Dec 31, 2025 |
All 443 Cardiff Lexington Corporation SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.